Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in ...

MORE than three decades have passed since the first attempt to treat myasthenia gravis with veratrum alkaloids. 1,2 At that time "Tinctura Veratri," given either intravenously or by mouth, was found ...

DEAR DR. ROACH: I have bulbar myasthenia gravis, which makes it difficult to eat. Can you tell me something about this disease and the odds of it spreading elsewhere in my body? — C.B. ANSWER: ...

Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and pathogenetic autoantibodies directed against the nicotinic acetylcholine receptor (seropositive myasthenia gravis; ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

Dear Dr. Roach • I have bulbar myasthenia gravis, which makes it difficult to eat. Can you tell me something about this disease and the odds of it spreading elsewhere in my body? — C.B. Answer • ...

Women with myasthenia gravis have higher rates of preterm birth and cesarean delivery, new findings show, underscoring the need for careful pregnancy management and monitoring.

Comorbidities and older age increase the risk of severe COVID-19 in MG patients, but not susceptibility to infection. MG treatments, including corticosteroids and immunosuppressants, do not heighten ...

A collaborative approach to myasthenia gravis This chronic autoimmune disorder is caused by antibodies that block muscle cells from receiving neurotransmitters from the nerve cell. Accreditation for ...

Results from the phase III VIBRANCE-MG study presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that nipocalimab (Imaavy) was safe and ...

Myasthenia gravis (MG) has been treatable for nearly 100 years. In 1934, the Scottish doctor Mary Broadfoot Walker, MD, discovered that the drug physostigmine improved muscle function in people with ...